BRAF and neoplasm: This subtype represents approximately 20% of colorectal cancers patients, and they include both BRAF-mutated tumours and BRAF wild-type tumors that share a similar gene expression pattern; therefore, sequencing the BRAF mutation alone is not sufficient to capture the whole population of the BRAF- mutation-like subtype.